Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

Market Cap	14.12B
Revenue (ttm)	5.18B
Net Income (ttm)	619.54M
Shares Out	889.45M
EPS (ttm)	0.70
PE Ratio	22.74
Forward PE	14.10
Dividend	0.30 (1.94%)
Ex-Dividend Date	Jul 4, 2024

Volume	26,836,827
Average Volume	25,605,783
Open	15.50
Previous Close	15.50
Day's Range	15.42 - 15.95
52-Week Range	11.83 - 18.41
Beta	0.47
RSI	71.21
Earnings Date	Aug 15, 2025

About SHA:603456

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization company in China and internationally. The company offers small molecule chemical drugs, peptide drugs, conjugated drugs, and small nucleic acid drugs. It serves global pharmaceutical companies, biotechnology companies, and research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 5,001
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603456

Financial Performance

In 2024, SHA:603456's revenue was 5.16 billion, a decrease of -6.57% compared to the previous year's 5.52 billion. Earnings were 606.10 million, a decrease of -41.34%.